Clinical Trial Update: Intra-lesional ACE Inhibitor for Treatment of Hypertrophic Scars [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial of an intralesional ACE inhibitor for hypertrophic scars has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Scar

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Hypertrophic Scar | Phase 2, Phase 3 | Status: WITHDRAWN